<DOC>
	<DOCNO>NCT01385735</DOCNO>
	<brief_summary>The current study aim assess effect 8 week Azilect treatment ( adjunct therapy levodopa ) affect perception emotional expressiveness double-blind placebo-controlled study .</brief_summary>
	<brief_title>Emotion , Mood Executive Function Parkinson ` Disease ( PD )</brief_title>
	<detailed_description>Parkinson ` disease ( PD ) associate range cognitive impairment , notably deficits high order cognitive control mechanism refer `` executive dysfunction '' . These problem consistently relate dysfunction fronto-striatal circuitry ( summary see Stocchi &amp; Brusa , 2000 ) . Executive function impairment may already present early stage PD ( Uekermann et al. , 2004 ) severity may exacerbate affective change depression ( Uekermann et al. , 2003 ) . In addition cognitive problem , PD patient frequently suffer mood change , particular apathy ( Kirsch-Darrow et al. , 2006 ) affect process impairment , relate ability decode affective state people basis facial expression prosody ability adequately express patient ` emotion ( e.g . Breitenstein et al. , 1998 ; Zgaljardic et al. , 2003 , Pell &amp; Leonard , 2005 ) . The capacity emotion perception find link severity executive dysfunction ; affective cognitive change thus independent , least patient moderate PD ( Breitenstein et al. , 2001 ) . In recent drug monitoring study Lundbeck GmbH/TEVA Pharma GmbH base small group PD patient ( n=29 ) , introduction Azilect ( Rasagiline ) therapy associate significant improvement PD patient ` emotional expressiveness ( e.g . facial expression , gesture , voice intonation ) 8 week observation period . Significant improvement observe self-ratings emotional expressiveness well rating physician relative . The lack placebo-control group , however , allow firm conclusion regard specificity effect . Intact affect recognition adequate ability express emotion critical importance social interaction . The therapeutic efficacy drug treatment non-motor symptom PD far rarely addressed . The documentation beneficial effect Azilect emotional processing would great relevance quality life PD patient greatly enhance ability participate social life . The addition placebo control group critical assessment specificity expect beneficial effect Azilect .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>idiopathic PD age range 3075 yr , HY IIII stable medication least 4 week prior baseline Native speaker ( German ) signing informed consent form clinically significant depression ( BDI &gt; 13 ) freezing , pronounced fluctuation neurological psychiatric disorder dementia ( MMSE &lt; 25 ) treatment MAOBinhibitor Selegiline , antidepressants contraindication accord SmPC participation another interventional study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Parkinson Disease</keyword>
	<keyword>Emotion</keyword>
	<keyword>mood</keyword>
	<keyword>executive function</keyword>
</DOC>